vs
Cooper Companies (The)（COO）与Copart（CPRT）财务数据对比。点击上方公司名可切换其他公司
Copart的季度营收约是Cooper Companies (The)的1.1倍（$1.2B vs $1.1B），Copart净利率更高（35.0% vs 7.9%，领先27.0%），Cooper Companies (The)同比增速更快（4.6% vs 0.7%），Copart自由现金流更多（$427.2M vs $149.9M），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 6.4%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
Copart是一家跨国在线车辆拍卖及再营销服务提供商，服务保险、租车、车队、金融公司等各类汽车经销商，业务覆盖美国、加拿大、英国、德国等11个国家。总部位于美国得克萨斯州达拉斯，拥有200多处实体网点，运营总面积超1万英亩的车辆存放场地。
COO vs CPRT — 直观对比
营收规模更大
CPRT
是对方的1.1倍
$1.1B
营收增速更快
COO
高出3.9%
0.7%
净利率更高
CPRT
高出27.0%
7.9%
自由现金流更多
CPRT
多$277.3M
$149.9M
两年增速更快
COO
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.2B |
| 净利润 | $84.6M | $403.7M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | 37.3% |
| 净利率 | 7.9% | 35.0% |
| 营收同比 | 4.6% | 0.7% |
| 净利润同比 | -28.0% | 11.5% |
| 每股收益（稀释后） | $0.42 | $0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOCPRT
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $964.7M | $1.2B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $1.1B | ||
| Q2 24 | $942.6M | $1.1B | ||
| Q1 24 | $931.6M | $1.0B |
净利润COOCPRT
| Q4 25 | $84.6M | $403.7M | ||
| Q3 25 | $98.3M | $396.4M | ||
| Q2 25 | $87.7M | $406.6M | ||
| Q1 25 | $104.3M | $387.4M | ||
| Q4 24 | $117.5M | $362.1M | ||
| Q3 24 | $104.7M | $322.6M | ||
| Q2 24 | $88.9M | $382.3M | ||
| Q1 24 | $81.2M | $325.6M |
毛利率COOCPRT
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | — | ||
| Q2 24 | 67.0% | — | ||
| Q1 24 | 67.0% | — |
营业利润率COOCPRT
| Q4 25 | 13.2% | 37.3% | ||
| Q3 25 | 16.6% | 36.7% | ||
| Q2 25 | 18.4% | 37.3% | ||
| Q1 25 | 18.9% | 36.6% | ||
| Q4 24 | 19.5% | 35.4% | ||
| Q3 24 | 19.2% | 33.6% | ||
| Q2 24 | 17.2% | 38.8% | ||
| Q1 24 | 16.4% | 37.2% |
净利率COOCPRT
| Q4 25 | 7.9% | 35.0% | ||
| Q3 25 | 9.3% | 35.2% | ||
| Q2 25 | 8.7% | 33.6% | ||
| Q1 25 | 10.8% | 33.3% | ||
| Q4 24 | 11.5% | 31.6% | ||
| Q3 24 | 10.4% | 30.2% | ||
| Q2 24 | 9.4% | 33.9% | ||
| Q1 24 | 8.7% | 31.9% |
每股收益（稀释后）COOCPRT
| Q4 25 | $0.42 | $0.41 | ||
| Q3 25 | $0.49 | $0.40 | ||
| Q2 25 | $0.44 | $0.42 | ||
| Q1 25 | $0.52 | $0.40 | ||
| Q4 24 | $0.59 | $0.37 | ||
| Q3 24 | $0.52 | $0.34 | ||
| Q2 24 | $0.44 | $0.39 | ||
| Q1 24 | $0.41 | $0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | — |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $8.2B | $9.6B |
| 总资产 | $12.4B | $10.6B |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资COOCPRT
| Q4 25 | $110.6M | — | ||
| Q3 25 | $124.9M | — | ||
| Q2 25 | $116.2M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $107.6M | — | ||
| Q3 24 | $109.7M | — | ||
| Q2 24 | $112.4M | — | ||
| Q1 24 | $135.2M | — |
总债务COOCPRT
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | $0 | ||
| Q2 24 | $2.7B | $427.0K | ||
| Q1 24 | $2.7B | $453.0K |
股东权益COOCPRT
| Q4 25 | $8.2B | $9.6B | ||
| Q3 25 | $8.4B | $9.2B | ||
| Q2 25 | $8.3B | $8.8B | ||
| Q1 25 | $8.1B | $8.3B | ||
| Q4 24 | $8.1B | $7.9B | ||
| Q3 24 | $7.9B | $7.5B | ||
| Q2 24 | $7.8B | $7.2B | ||
| Q1 24 | $7.7B | $6.8B |
总资产COOCPRT
| Q4 25 | $12.4B | $10.6B | ||
| Q3 25 | $12.4B | $10.1B | ||
| Q2 25 | $12.4B | $9.7B | ||
| Q1 25 | $12.2B | $9.2B | ||
| Q4 24 | $12.3B | $8.9B | ||
| Q3 24 | $12.1B | $8.4B | ||
| Q2 24 | $12.0B | $8.0B | ||
| Q1 24 | $12.0B | $7.6B |
负债/权益比COOCPRT
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | 0.00× | ||
| Q2 24 | 0.34× | 0.00× | ||
| Q1 24 | 0.35× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $535.3M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $427.2M |
| 自由现金流率自由现金流/营收 | 14.1% | 37.0% |
| 资本支出强度资本支出/营收 | 9.2% | 9.4% |
| 现金转化率经营现金流/净利润 | 2.93× | 1.33× |
| 过去12个月自由现金流最近4个季度 | $433.7M | $1.4B |
8季度趋势，按日历期对齐
经营现金流COOCPRT
| Q4 25 | $247.9M | $535.3M | ||
| Q3 25 | $261.4M | $438.5M | ||
| Q2 25 | $96.2M | $700.9M | ||
| Q1 25 | $190.6M | $178.1M | ||
| Q4 24 | $268.1M | $482.3M | ||
| Q3 24 | $207.5M | $439.2M | ||
| Q2 24 | $111.0M | $496.3M | ||
| Q1 24 | $122.7M | $161.8M |
自由现金流COOCPRT
| Q4 25 | $149.9M | $427.2M | ||
| Q3 25 | $164.5M | $350.8M | ||
| Q2 25 | $18.1M | $572.9M | ||
| Q1 25 | $101.2M | $61.5M | ||
| Q4 24 | $128.1M | $245.5M | ||
| Q3 24 | $118.5M | $301.3M | ||
| Q2 24 | $36.9M | $408.5M | ||
| Q1 24 | $4.6M | $38.8M |
自由现金流率COOCPRT
| Q4 25 | 14.1% | 37.0% | ||
| Q3 25 | 15.5% | 31.2% | ||
| Q2 25 | 1.8% | 47.3% | ||
| Q1 25 | 10.5% | 5.3% | ||
| Q4 24 | 12.6% | 21.4% | ||
| Q3 24 | 11.8% | 28.2% | ||
| Q2 24 | 3.9% | 36.2% | ||
| Q1 24 | 0.5% | 3.8% |
资本支出强度COOCPRT
| Q4 25 | 9.2% | 9.4% | ||
| Q3 25 | 9.1% | 7.8% | ||
| Q2 25 | 7.8% | 10.6% | ||
| Q1 25 | 9.3% | 10.0% | ||
| Q4 24 | 13.7% | 20.6% | ||
| Q3 24 | 8.9% | 12.9% | ||
| Q2 24 | 7.9% | 7.8% | ||
| Q1 24 | 12.7% | 12.1% |
现金转化率COOCPRT
| Q4 25 | 2.93× | 1.33× | ||
| Q3 25 | 2.66× | 1.11× | ||
| Q2 25 | 1.10× | 1.72× | ||
| Q1 25 | 1.83× | 0.46× | ||
| Q4 24 | 2.28× | 1.33× | ||
| Q3 24 | 1.98× | 1.36× | ||
| Q2 24 | 1.25× | 1.30× | ||
| Q1 24 | 1.51× | 0.50× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
CPRT
| Services | $952.1M | 82% |
| Other | $203.0M | 18% |
